Momenta Pharmaceuticals Presents Preclinical Data for Novel Anticoagulant M118 At American College of Cardiology
March 26, 2007 13:30 ET
|
Momenta Pharmaceuticals
NEW ORLEANS, March 26, 2007 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals to Present At the Cowen and Company 27th Annual Health Care Conference
March 08, 2007 12:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., March 8, 2007 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs,...
Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter of 2006 and Announces 2007 Goals
February 13, 2007 07:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 13, 2007 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals to Present At BIO CEO & Investor Conference 2007
February 06, 2007 15:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 6, 2007 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, announced...
Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Fourth Quarter 2006 Financial Results
January 23, 2007 11:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Jan. 23, 2007 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...